Role of GDF-15 and NRG-1 as predictive markers of coronary artery disease

Monika Samra1,2, Indu Arora2, Rajiv Narang3

  • 1Dr. B R Ambedkar Centre for Biomedical Research, University of Delhi, Delhi, 110007, India.

PubMed

Insights

The GDF15 rs4808793 polymorphism and elevated GDF15 and NRG1 gene expression are significantly linked to coronary artery disease (CAD). These factors may serve as valuable biomarkers for predicting CAD severity and guiding patient management.

Area of Science:

  • Genetics and Molecular Biology
  • Cardiovascular Disease Research

Background:

  • Coronary artery disease (CAD) presents a significant global health burden, with diagnostic challenges persisting.
  • This study investigates the genetic and molecular associations of GDF15 and NRG1 with CAD.

Purpose of the Study:

  • To examine the association between the GDF15 -3148 C/G (rs4808793) polymorphism and CAD.
  • To evaluate GDF15 and NRG1 gene and protein expression levels in CAD patients.
  • To determine the potential of these markers in predicting CAD severity.

Main Methods:

  • Genotyping of GDF15 rs4808793 polymorphism using PCR-RFLP in CAD patients and controls.
  • Quantification of GDF15 and NRG1 mRNA and protein expression via real-time PCR, Western blot, and ELISA.

Main Results:

  • The GDF15 (CG+GG) genotype was significantly associated with CAD (p < 0.0001).
  • Elevated GDF15 and NRG1 mRNA and protein levels were observed in CAD patients compared to controls (p < 0.0001).
  • Receiver Operating Characteristic (ROC) curve analysis indicated strong discriminatory power for both markers, correlating positively with disease severity.

Conclusions:

  • The GDF15 rs4808793 polymorphism is significantly associated with CAD.
  • Elevated GDF15 and NRG1 expression levels are linked to CAD.
  • These findings suggest GDF15 and NRG1 may serve as predictive biomarkers for CAD severity and management.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
541
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
893
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
376
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
219
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
332
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
591